Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR (NASDAQ:EVO) in a deal valued at approximately 2 billion euros ($2.10 billion), to ...

Fidelity International Capital Appreciation Fund is a diversified international equity strategy that seeks capital growth by ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

That’s what has fascinated the editors of Canada’s Top 100 Employers since the annual competition launched in 2000 to ...

Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the ...

The pound has dropped to its lowest level in over four months amid mounting concerns over the state of the UK economy.

↘️ Applied Materials (AMAT): Shares fell 8% after the semiconductor-equipment company posted a weaker-than-expected sales ...

U.S. stock futures pointed to another day of losses Friday as investors absorbed the message of Fed Chair Jerome Powell that ...